FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,914 | -68.0% | 12,648 | 0.0% | 0.00% | – |
| Q2 2023 | $34,150 | -85.5% | 12,648 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $236,012 | +13.5% | 12,648 | -2.6% | 0.00% | +50.0% |
| Q4 2022 | $208,004 | -99.9% | 12,984 | -48.8% | 0.00% | 0.0% |
| Q3 2022 | $165,165,000 | +123157.5% | 25,356 | +100.5% | 0.00% | +100.0% |
| Q2 2022 | $134,000 | -17.3% | 12,648 | -5.9% | 0.00% | -50.0% |
| Q1 2022 | $162,000 | -3.6% | 13,448 | +12.6% | 0.00% | 0.0% |
| Q4 2021 | $168,000 | +9.8% | 11,948 | -20.1% | 0.00% | 0.0% |
| Q3 2021 | $153,000 | -73.2% | 14,948 | -30.3% | 0.00% | -66.7% |
| Q2 2021 | $571,000 | +46.8% | 21,448 | +91.2% | 0.01% | +20.0% |
| Q1 2021 | $389,000 | -11.6% | 11,219 | -3.3% | 0.01% | 0.0% |
| Q4 2020 | $440,000 | – | 11,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |